Metabolic and Low-Grade Inflammation Risk in Young Adults with a History of Extrauterine Growth Restriction
- PMID: 38892541
- PMCID: PMC11174372
- DOI: 10.3390/nu16111608
Metabolic and Low-Grade Inflammation Risk in Young Adults with a History of Extrauterine Growth Restriction
Abstract
Children with a history of extrauterine growth restriction (EUGR), later at prepubertal age, exhibit an increased metabolic risk including risen insulin resistance and low-grade inflammation. However, the progression of such metabolic changes after puberty and the lasting health implications have not yet been investigated. The objective of this study was to ascertain whether young adults with a history of EUGR faced increased vulnerability to metabolic disorders. A study was conducted comparing a group of adults with a history of EUGR with a healthy reference group. A total of 110 young adults (36 from the EUGR group and 74 from the control group) were included. Anthropometric variables, blood pressure (BP), general biochemical parameters, plasma inflammatory biomarkers, and adipokines were assessed. Compared to the reference group, the EUGR group had a shorter height and body weight with higher lean mass and waist circumference, as well as a greater percentage of individuals with high BP. In addition, EUGR patients had higher values of insulin, HOMA-IR, nerve growth factor, and leptin, and lower levels of adiponectin and resistin. The present study suggests that young adults with a history of EUGR present increased metabolic risk factors therefore, clinical follow-up should be considered.
Keywords: adipokines; extrauterine growth restriction; inflammation; insulin resistance; metabolism; nutrition.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.
Figures


Similar articles
-
Changes in plasma adipokines in prepubertal children with a history of extrauterine growth restriction.Nutrition. 2013 Nov-Dec;29(11-12):1321-5. doi: 10.1016/j.nut.2013.04.015. Epub 2013 Sep 5. Nutrition. 2013. PMID: 24012390
-
Metabolic and inflammatory status in prepuberty and early adulthood for individuals with a history of extrauterine growth restriction: a cohort study.J Transl Med. 2025 Jan 14;23(1):67. doi: 10.1186/s12967-024-06053-2. J Transl Med. 2025. PMID: 39810203 Free PMC article.
-
Plasma Adipokines Profile in Prepubertal Children with a History of Prematurity or Extrauterine Growth Restriction.Nutrients. 2020 Apr 24;12(4):1201. doi: 10.3390/nu12041201. Nutrients. 2020. PMID: 32344627 Free PMC article.
-
Comorbidities in childhood associated with extrauterine growth restriction in preterm infants: a scoping review.Eur J Pediatr. 2020 Aug;179(8):1255-1265. doi: 10.1007/s00431-020-03613-8. Epub 2020 Feb 24. Eur J Pediatr. 2020. PMID: 32096070
-
Extrauterine growth retardation in premature infants in Shanghai: a multicenter retrospective review.Eur J Pediatr. 2009 Sep;168(9):1055-9. doi: 10.1007/s00431-008-0885-9. Epub 2008 Dec 19. Eur J Pediatr. 2009. PMID: 19096875 Review.
Cited by
-
Evaluating Prevalence of Preterm Postnatal Growth Faltering Using Fenton 2013 and INTERGROWTH-21st Growth Charts with Logistic and Machine Learning Models.Nutrients. 2025 May 20;17(10):1726. doi: 10.3390/nu17101726. Nutrients. 2025. PMID: 40431467 Free PMC article.
References
-
- Ohuma E.O., Moller A.B., Bradley E., Chakwera S., Hussain-Alkhateeb L., Lewin A., Okwaraji Y.B., Mahanani W.R., Johansson E.W., Lavin T., et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: A systematic analysis. Lancet. 2023;402:1261–1271. doi: 10.1016/S0140-6736(23)00878-4. - DOI - PubMed
-
- World Health Organization . Born Too Soon: Decade of Action on Preterm Birth. World Health Organization; Geneva, Switzerland: 2023.
-
- Melamed N., Baschat A., Yinon Y., Athanasiadis A., Mecacci F., Figueras F., Berghella V., Nazareth A., Tahlak M., McIntyre H.D., et al. FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction. Int. J. Gynecol. Obstet. 2021;152:3–57. doi: 10.1002/ijgo.13522. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources